These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35394718)

  • 1. [SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):38-45. PubMed ID: 35394718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.
    Bernetti A; Mangone M; Villani C; Alviti F; Valeo M; Grassi MC; Migliore A; Viora U; Adriani E; Quirino N; Fioravanti A; Paoloni M
    Eur J Phys Rehabil Med; 2019 Oct; 55(5):658-664. PubMed ID: 31106560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting.
    Bruyère O; Cooper C; Pelletier JP; Maheu E; Rannou F; Branco J; Luisa Brandi M; Kanis JA; Altman RD; Hochberg MC; Martel-Pelletier J; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S3-11. PubMed ID: 26806188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
    Rovati LC; Girolami F; D'Amato M; Giacovelli G
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S34-41. PubMed ID: 26632505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
    Bruyère O; Altman RD; Reginster JY
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S12-7. PubMed ID: 26806187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint.
    Zhang Z; Huang C; Cao Y; Mu R; Zhang MC; Xing D; Fan D; Ding Y; Guo J; Hou Y; Jianhao L; Veronese N; Reginster JY; Bruyere O; Cavalier E; Zhang H
    Aging Clin Exp Res; 2021 Aug; 33(8):2141-2147. PubMed ID: 34189714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review of chondroitin sulfate in osteoarthritis.
    Uebelhart D
    Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations].
    Shavlovskaya OA
    Ter Arkh; 2021 Dec; 93(12):1551-1555. PubMed ID: 36286687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on recent therapeutic guidelines for osteoarthritis.
    Cutolo M; Berenbaum F; Hochberg M; Punzi L; Reginster JY
    Semin Arthritis Rheum; 2015 Jun; 44(6):611-7. PubMed ID: 25677861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Bruyère O; Cooper C; Al-Daghri NM; Dennison EM; Rizzoli R; Reginster JY
    Aging Clin Exp Res; 2018 Feb; 30(2):111-117. PubMed ID: 29177637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.
    Rabade A; Viswanatha GL; Nandakumar K; Kishore A
    Inflammopharmacology; 2024 Jun; 32(3):1759-1775. PubMed ID: 38581640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Management of Osteoarthritis With a Focus on Symptomatic Slow-Acting Drugs: Recommendations From Leading Russian Experts.
    Alexander LAM; Ln D; Eg Z; Is D; Ay K; Ss R; Ea T; Sp Y; Ez Y; L G
    J Clin Rheumatol; 2021 Dec; 27(8):e533-e539. PubMed ID: 32732520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2019 revised algorithm for the management of knee osteoarthritis: the Southeast Asian viewpoint.
    Yeap SS; Tanavalee A; Perez EC; Tan MP; Reyes BHM; Lee JK; Norhamdan MY; Vista ES; Chan WS; Cong SB; Tam PTT; Kaufman JM; Reginster JY; Veronese N; Penserga E
    Aging Clin Exp Res; 2021 May; 33(5):1149-1156. PubMed ID: 33774784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative analysis of the use of symptomatic slow acting drugs for osteoarthritis containing chondroitin sulfate or affecting its biosynthesis in patients with non-specific low back pain].
    Sarvilina IV; Danilov AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):81-96. PubMed ID: 36719123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
    Vangsness CT; Spiker W; Erickson J
    Arthroscopy; 2009 Jan; 25(1):86-94. PubMed ID: 19111223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
    Bruyère O; Burlet N; Delmas PD; Rizzoli R; Cooper C; Reginster JY
    BMC Musculoskelet Disord; 2008 Dec; 9():165. PubMed ID: 19087296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chondroitin sulfate role in the complex rehabilitation of elderly people with chronic pain syndrome].
    Shavlovskaya OA; Razumov AN; Bokova IA; Shavlovskiy NI; Yukhnovskaya YD
    Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(1):71-78. PubMed ID: 33605133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation.
    Black C; Clar C; Henderson R; MacEachern C; McNamee P; Quayyum Z; Royle P; Thomas S
    Health Technol Assess; 2009 Nov; 13(52):1-148. PubMed ID: 19903416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis.
    Kucharz EJ; Szántó S; Ivanova Goycheva M; Petronijević M; Šimnovec K; Domżalski M; Gallelli L; Kamenov Z; Konstantynowicz J; Radunović G; Šteňo B; Stoilov R; Stok R; Vrana R; Bruyère O; Cooper C; Reginster JY
    Rheumatol Int; 2019 Jul; 39(7):1117-1123. PubMed ID: 31129712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent?
    Stellavato A; Restaino OF; Vassallo V; Finamore R; Ruosi C; Cassese E; De Rosa M; Schiraldi C
    Adv Ther; 2019 Nov; 36(11):3221-3237. PubMed ID: 31494830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.